344 related articles for article (PubMed ID: 31025922)
21. Increase in the length of superficial temporal artery biopsy over 14 years.
Au CP; Sharma NS; McCluskey P; Ghabrial R
Clin Exp Ophthalmol; 2016 Sep; 44(7):550-554. PubMed ID: 26929005
[TBL] [Abstract][Full Text] [Related]
22. Subtleties in the histopathology of giant cell arteritis.
Stacy RC; Rizzo JF; Cestari DM
Semin Ophthalmol; 2011; 26(4-5):342-8. PubMed ID: 21958185
[TBL] [Abstract][Full Text] [Related]
23. Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis.
Espígol-Frigolé G; Corbera-Bellalta M; Planas-Rigol E; Lozano E; Segarra M; García-Martínez A; Prieto-González S; Hernández-Rodríguez J; Grau JM; Rahman MU; Cid MC
Ann Rheum Dis; 2013 Sep; 72(9):1481-7. PubMed ID: 22993227
[TBL] [Abstract][Full Text] [Related]
24. Is all inflammation within temporal artery biopsies temporal arteritis?
Jia L; Couce M; Barnholtz-Sloan JS; Cohen ML
Hum Pathol; 2016 Nov; 57():17-21. PubMed ID: 27445262
[TBL] [Abstract][Full Text] [Related]
25. The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis.
Jakobsson K; Jacobsson L; Mohammad AJ; Nilsson JÅ; Warrington K; Matteson EL; Turesson C
BMC Musculoskelet Disord; 2016 Aug; 17(1):363. PubMed ID: 27558589
[TBL] [Abstract][Full Text] [Related]
26. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis?
Achkar AA; Lie JT; Hunder GG; O'Fallon WM; Gabriel SE
Ann Intern Med; 1994 Jun; 120(12):987-92. PubMed ID: 8185147
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic correlations in giant cell arteritis: a retrospective study of 107 cases.
Zhou L; Luneau K; Weyand CM; Biousse V; Newman NJ; Grossniklaus HE
Ophthalmology; 2009 Aug; 116(8):1574-80. PubMed ID: 19500846
[TBL] [Abstract][Full Text] [Related]
28. Association between histological features in temporal artery biopsies and clinical features of patients with giant cell arteritis.
Breuer GS; Nesher R; Reinus K; Nesher G
Isr Med Assoc J; 2013 Jun; 15(6):271-4. PubMed ID: 23882888
[TBL] [Abstract][Full Text] [Related]
29. Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case-control study.
Prieto-González S; Depetris M; García-Martínez A; Espígol-Frigolé G; Tavera-Bahillo I; Corbera-Bellata M; Planas-Rigol E; Alba MA; Hernández-Rodríguez J; Grau JM; Lomeña F; Cid MC
Ann Rheum Dis; 2014 Jul; 73(7):1388-92. PubMed ID: 24665112
[TBL] [Abstract][Full Text] [Related]
30. Temporal Artery Biopsy: When Is It Worth the Headache?
Bomkamp BT; Borgert AJ; Fitzsimmons AJ; Smith TJ; Shakhnovich I; Peschman JR
WMJ; 2023 Mar; 122(1):38-43. PubMed ID: 36940120
[TBL] [Abstract][Full Text] [Related]
31. Diagnosing an atypical site of giant cell arteritis with magnetic resonance angiography: a case report.
Tan BL; Liu JJ; Yong TY; Tan CC; Li JY
J Med Case Rep; 2016 Jun; 10(1):179. PubMed ID: 27334918
[TBL] [Abstract][Full Text] [Related]
32. The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries.
Brodmann M; Lipp RW; Passath A; Seinost G; Pabst E; Pilger E
Rheumatology (Oxford); 2004 Feb; 43(2):241-2. PubMed ID: 13130153
[TBL] [Abstract][Full Text] [Related]
33. Temporal artery biopsies: do they make the cut?
McMurran AE; Boom SJ
Scott Med J; 2015 Feb; 60(1):9-12. PubMed ID: 25361572
[TBL] [Abstract][Full Text] [Related]
34. Expression of the class I interferon-related MxA protein in temporal arteries in polymyalgia rheumatica and temporal arteritis.
Nordborg C; Larsson K; Aman P; Nordborg E
Scand J Rheumatol; 2009; 38(2):144-8. PubMed ID: 19177264
[TBL] [Abstract][Full Text] [Related]
35. Comparison between color duplex ultrasonography and histology of the temporal artery in cranial arteritis (giant cell arteritis).
Schmidt D; Hetzel A; Reinhard M; Auw-Haedrich C
Eur J Med Res; 2003 Jan; 8(1):1-7. PubMed ID: 12578748
[TBL] [Abstract][Full Text] [Related]
36. CD3 immunohistochemistry is helpful in the diagnosis of giant cell arteritis.
Ciccia F; Ferrante A; Guggino G; Cavazza A; Salvarani C; Rizzo A
Rheumatology (Oxford); 2018 Aug; 57(8):1377-1380. PubMed ID: 29697809
[TBL] [Abstract][Full Text] [Related]
37. The effect of temporal artery biopsy on the treatment of temporal arteritis.
Le K; Bools LM; Lynn AB; Clancy TV; Hooks WB; Hope WW
Am J Surg; 2015 Feb; 209(2):338-41. PubMed ID: 25457237
[TBL] [Abstract][Full Text] [Related]
38. Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis.
Muratore F; Boiardi L; Cavazza A; Aldigeri R; Pipitone N; Restuccia G; Bellafiore S; Cimino L; Salvarani C
J Autoimmun; 2016 May; 69():94-101. PubMed ID: 27009904
[TBL] [Abstract][Full Text] [Related]
39. Factors associated to temporal artery biopsy result in suspects of giant cell arteritis: a retrospective, multicenter, case-control study.
González-López JJ; González-Moraleja J; Burdaspal-Moratilla A; Rebolleda G; Núñez-Gómez-Álvarez MT; Muñoz-Negrete FJ
Acta Ophthalmol; 2013 Dec; 91(8):763-8. PubMed ID: 22938720
[TBL] [Abstract][Full Text] [Related]
40. Ultrasound versus temporal artery biopsy in patients with Giant cell arteritis: a prospective cohort study.
Zou Q; Ma S; Zhou X
BMC Med Imaging; 2019 Jun; 19(1):47. PubMed ID: 31170909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
